<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TECHNION-ISRAEL_kill_switch skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TECHNION-ISRAEL/kill switch</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>navbar</TITLE></P><DIV class="container-fluid" style="margin-top:0px;"><DIV class="row"><DIV class="col-md-12"><NAV class="navbar navbar-inverse navbar-fixed-top " style=" z-index:800; position:fixed; margin:auto; width: 1180px ;"><DIV class="dropdown" style="padding-left: 100px;"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown"><A href="https://2017.igem.org/Team:TECHNION-ISRAEL"> project </A></BUTTON><UL class="dropdown-menu" style=" margin: 0px;  left:78px;"><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Description"> description </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Diseases"> Diseases &amp; Epitopes </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Design"><SPAN id="T">T</SPAN>ri-Display </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/delay_mechanism"><SPAN id="T">  T</SPAN>iming </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/kill_switch"><SPAN id="T">T</SPAN>erminate</A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Demonstrate"><SPAN id="T"> T</SPAN>olerance Assay </A></LI></UL></DIV><DIV class="dropdown"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown"> wet lab 
							</BUTTON><UL class="dropdown-menu" style="margin: 0px;  left: 2px;"><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/cell_lines"> cell lines </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Results"> results </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/hpc7"> hpc-7 results </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Notebook"> notebook </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Experiments"> protocols </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/InterLab"> interlab </A></LI></UL></DIV><DIV class="dropdown"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown"><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Parts"> parts </A></BUTTON><UL class="dropdown-menu" style="margin: 0px;  left: 2px;"><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Parts"> parts </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Basic_Part"> basic part </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Composite_Part"> composite part </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Part_Collection"> part collection </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Improve">	 improvement </A></LI></UL></DIV><DIV class="dropdown"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown" style="width: auto"> human practices 
							</BUTTON><UL class="dropdown-menu" style="margin: 0px;  left: 18px; width: 170px;"><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/HP/Silver"> HP silver </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Engagement"> Education &amp; Public Engagement </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/HP/Gold_Integrated"> integrated HP </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/ethics"> ethics </A></LI></UL></DIV><DIV class="dropdown"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown"> judging
							</BUTTON><UL class="dropdown-menu" style="margin: 0px;  left: 2px "><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Safety"> safety </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Collaborations"> collaboration </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Achievements"> achievements </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Model"> modelling </A></LI></UL></DIV><DIV class="dropdown" style="padding-right: 100px;"><BUTTON class="dropdown-toggle" type="button" data-toggle="dropdown">team
							</BUTTON><UL class="dropdown-menu" style=" margin: 0px;  left: 2px;"><LI><A href=" https://2017.igem.org/Team:TECHNION-ISRAEL/Team"> members </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/Attributions"> attributions </A></LI><LI><A href="https://2017.igem.org/Team:TECHNION-ISRAEL/gallery"> gallery </A></LI></UL></DIV></NAV></DIV></DIV></DIV><P><TITLE>Kill Switch</TITLE></P><DIV class="container-fluid"><DIV class="row"><DIV class="col-md-offset-2 col-md-8"><DIV class="row"><DIV class="col-md-12"><H4 style="text-align:center;">
							Ganciclovir Kill Switch
							</H4><P>
							In light of our <A target="_blank" href="https://2017.igem.org/Team:TECHNION-ISRAEL/delay_mechanism">delay mechanism</A> epitopes are displayed on the cellular membrane only after engraftment within the bone marrow. Unfortunately no biologically inducible system is perfect and there will always be a basal level of “leakiness”. Additionally, bone marrow cells routinely migrate to the bloodstream. For this reason, as well as ethical considerations, we have implemented a &quot;Kill switch&quot; based on the use of the Ganciclovir prodrug and transfection of the Herpes Simplex Virus – Thymidine Kinase (HSV-TK). 
							</P><P>Transfection of HSV-TK, followed by treatment with the prodrug ganciclovir (GCV), is one of the most commonly used<SUP id="cite ref-1 " class="reference"><A href="#ref1" original-title="">[1] </A></SUP>
 experimental and clinical methods for Gene-Directed Enzyme Prodrug Therapy (GDEPT). 
							The concept of GDEPT has existed for over 20 years, but its clinical importance has grown exponentially in the past 5 years with more and more GDEPT based systems entering clinical trials. GDEPT systems are comprised of three components: An inactive drug (“prodrug”), a gene coding for an enzyme that converts the inactive prodrug to an active drug, and a delivery mechanism. Ideally, the prodrug should be non-toxic or minimally toxic prior to activation by enzyme but highly toxic after enzymatic activation
							<SUP id="cite ref-1 " class="reference"><A href="#ref1" original-title="">[1] </A></SUP>.
							</P><P>As shown below expression of HSV-TK gene leads to the synthesis of viral thymidine kinases. These kinases convert GCV into GCV monophosphate which is subsequently converted into a toxic triphosphate form by natural cellular kinases. GCV triphosphate is analogous to 2'-deoxyguanosine triphosphate (dGTP) and therefore incorporates into replicating DNA causing premature strand termination, replication failure and apoptosis <STRONG> (Figure 1)</STRONG><SUP id="cite ref-2 " class="reference"><A href="#ref2" original-title="">[2] </A></SUP>.
							</P><P style="text-align: center;"><STRONG>Figure 1:</STRONG> The Ganciclovir System </P><P><STRONG>Our goal </STRONG> is to add an additional cistron, which will code for HSV-TK, to our <A target="_blank" href="https://2017.igem.org/Team:TECHNION-ISRAEL/Design">display mechanism.</A> Accordingly, transfected HSCs expressing epitope will concurrently express HSV-TK. In the case of an allergic reaction, or patient dissatisfaction, treatment with Ganciclovir will induce apoptosis in all epitope expressing HSCs.
							</P><DIV class="references"><OL><LI id="ref1"> Niculescu-Duvaz, Ion, et al. &quot;Gene-directed enzyme prodrug therapy.&quot; <I> Bioconjugate chemistry </I> 9.1 (1998): 4-22.‏</LI><LI id="ref2"> Zhang, Jin, Vijay Kale, and Mingnan Chen. &quot;Gene-directed enzyme prodrug therapy.&quot; <I>The AAPS journal 17.1</I> (2015): 102-110.‏</LI></OL></DIV></DIV></DIV></DIV></DIV></DIV><TITLE>My First Website</TITLE><DIV class="footer"><DIV class="container-fluid"><DIV class="row"><DIV class="col-md-offset-1 col-md-10"><DIV class="row"><DIV class="col-md-4 nopadding"><DIV class="location"><P style="text-indent:inherit; margin-top: 30px; padding-bottom:15px;color:  #ffffff; 	font-family:  'Quicksand', sans-serif; 	font-size: 14px; 	line-height:25px; 	text-align: unset;">
											
							Department of Biotechnology &amp; Food Engineering
							
							
							Technion – Israel Institute of Technology
							
							
							Haifa 32000, Israel
							</P></DIV></DIV><DIV class="col-md-offset-3 col-md-3"><DIV class="contact" style="margin-top: 20px;"><UL><P style=" text-indent:inherit; margin-top: 5px; color:  #ffffff; font-family: 'Quicksand', sans-serif;	font-size: 14px;">
									igem.technion.2017@gmail.com
									</P></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>